Akèy › Sarkom tisi mou › New York
Etid klinik pou Sarkom tisi mou nan New York
28 etid pou Sarkom tisi mou ap chèche patisipan nan sit nan New York.
Vil nan New York
- New York City20 etid
- Queens9 etid
- Greenburgh7 etid
- Staten Island6 etid
- New Rochelle6 etid
- The Bronx3 etid
Tèks ofisyèl etid la (Anglè)
A Study of CRD3874-SI in People With Solid Tumors
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- ak 1 plis
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT06021626First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma
- Memorial Sloan Kettering Cancer Center, New York
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT06797999Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
- New York University Langone Health, New York
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT05732831Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
- Memorial Sloan Kettering Cancer Center, New York
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT04577014Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Ap rekriteFaz 1
Laj 12 a 85 · Tout sèks · Mizajou Sep 8, 2026 · NCT03715933First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT06644755Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma
- Montefiore Medical Center, The Bronx
Ap rekriteFaz 1/2
Laj 12 a 40 · Tout sèks · Mizajou Sep 3, 2026 · NCT07725380A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
- Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- ak 1 plis
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT05837767Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Queens Hospital Center, Jamaica
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Stony Brook University Medical Center, Stony Brook
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 40 a 75 · Tout sèks · Mizajou Sep 2, 2026 · NCT05334069Actinium Therapy for Late-stage Aggressive Sarcomas
- Memorial Sloane Kettering Cancer Center, New York
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 28, 2026 · NCT07156565STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas
- Northwell Health Cancer Institute, Lake Success
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT06975293Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases
- Roswell Park Cancer Institute, Buffalo
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 21, 2026 · NCT03965234A Study of MGC026 in Participants With Advanced Solid Tumors
- START-New York Long Island, Lake Success
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT06242470Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
- Memorial Sloan Kettering Commack (Consent and Follow-Up), Commack
- Memorial Sloan Kettering Westchester (Consent and Followup), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- ak 1 plis
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Jul 30, 2026 · NCT00579566A Study of Pembrolizumab in People With Ultra-Rare Sarcomas
- Memorial Sloan Kettering Cancer Center Suffolk- Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering at Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- ak 1 plis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 28, 2026 · NCT07089992Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors
- Zai Lab Site 02002, New York
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jul 23, 2026 · NCT07374848Integrated Cancer Repository for Cancer Research
- C.R. Wood Cancer Center, Glens Falls Hospital, Glens Falls
- Faxton St. Luke's Healthcare, Mohawk Valley, Utica
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 19 a 110 · Tout sèks · Mizajou Jun 29, 2026 · NCT02012699A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours
- Memorial Sloan Kettering Cancer Center, New York
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou May 15, 2026 · NCT04969835Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With Sarcoma
- Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities ), Commack
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All protocol activites), New York
- ak 1 plis
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou May 15, 2026 · NCT06129903A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg
- Memorial Sloan Kettering Cancer Center @ Suffolk - Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center, New York
- ak 1 plis
Ap rekriteFaz 2
Laj 12 ak plis · Tout sèks · Mizajou Apr 23, 2026 · NCT04332874Brief Title Mechanisms of Cancer-Related Pain and Opioid Use Among Adolescents and Young Adult Sarcoma Survivors: Pilot Feasibility Study
- Roswell Park Comprehensive Cancer Center, Buffalo
Ap rekriteEtid obsèvasyon
Laj 12 a 70 · Tout sèks · Mizajou Apr 15, 2026 · NCT07402577A Clinical Study to Investigate the Efficacy of Intratumoral Tigilanol Tiglate in Soft Tissue Sarcoma
- Memorial Sloan Kettering Cancer Centre, New York
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Mar 12, 2026 · NCT05755113Phase II Trial of Lung Chemoemobolization
- Memorial Sloan Kettering Cancer Center, New York
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Mar 5, 2026 · NCT05672108Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- Albert Einstein College of Medicine, Children's Hospital at Montefiore, The Bronx
- New York Medical Center/ Maria Fareri Children's Hospital, Valhalla
Ap rekriteFaz 1/2
12 Months – 40 Years · Tout sèks · Mizajou Feb 5, 2026 · NCT03465592Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
- Memorial Sloan Kettering Cancer Center, New York
Ap rekriteFaz 1/2
Laj 2 a 30 · Tout sèks · Mizajou Feb 3, 2026 · NCT05734066A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma
- Memorial Sloan Kettering Cancer Center, New York
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Dec 26, 2025 · NCT06942442A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
- Children's Hospital at Montefiore, The Bronx
Ap rekriteFaz 2
18 Months – 40 Years · Tout sèks · Mizajou Aug 12, 2025 · NCT05135975A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
- Memorial Sloan-Kettering Cancer Center, New York
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Nov 25, 2024 · NCT05824975Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.